Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001724287-19-000001
Filing Date
2019-03-08
Accepted
2019-03-08 07:58:37
Documents
1
Effectiveness Date
2019-03-08
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10412
  Complete submission text file 0001724287-19-000001.txt   11504
Mailing Address 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL 35215
Business Address 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL 35215 251-401-1187
Bridge Therapeutics, Inc. (Filer) CIK: 0001724287 (see all company filings)

EIN.: 473513057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-306250 | Film No.: 19667613